TW297025B - - Google Patents

Download PDF

Info

Publication number
TW297025B
TW297025B TW082100365A TW82100365A TW297025B TW 297025 B TW297025 B TW 297025B TW 082100365 A TW082100365 A TW 082100365A TW 82100365 A TW82100365 A TW 82100365A TW 297025 B TW297025 B TW 297025B
Authority
TW
Taiwan
Prior art keywords
compound
biphenyl
patent application
item
oxy
Prior art date
Application number
TW082100365A
Other languages
English (en)
Chinese (zh)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of TW297025B publication Critical patent/TW297025B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW082100365A 1992-02-14 1993-01-20 TW297025B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83778292A 1992-02-14 1992-02-14

Publications (1)

Publication Number Publication Date
TW297025B true TW297025B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-02-01

Family

ID=25275409

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082100365A TW297025B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-02-14 1993-01-20

Country Status (16)

Country Link
EP (1) EP0556060A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH05286939A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR930017891A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1044243C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU656454B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2089185A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI930621A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU217627B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL104623A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9300742A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO930520L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ245757A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL172241B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2122540C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW297025B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA93531B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767129A (en) * 1995-08-24 1998-06-16 Warner-Lambert Company Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
EP1411929B1 (en) 2001-01-26 2011-05-11 Chugai Seiyaku Kabushiki Kaisha Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
DE60219595T2 (de) 2001-01-26 2008-01-10 Chugai Seiyaku K.K. Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren
WO2002064136A2 (en) 2001-01-26 2002-08-22 Chugai Seiyaku Kabushiki Kaisha Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
PT1370260E (pt) 2001-02-20 2011-02-01 Chugai Pharmaceutical Co Ltd Azóis como inibidores da malonil-coa-descarboxilase úteis como moduladores metabólicos
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
RU2201753C1 (ru) * 2002-03-12 2003-04-10 Нестерук Владимир Викторович Фармацевтическая композиция, обладающая диуретическим, дегидратирующим и гипотензивным действием
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7786145B2 (en) 2003-08-01 2010-08-31 Chugai Seiyaku Kabushiki Kaisha Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors
WO2005011670A1 (en) 2003-08-01 2005-02-10 Chugai Seiyaku Kabushiki Kaisha Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
JP4648317B2 (ja) 2003-08-01 2011-03-09 中外製薬株式会社 マロニル−CoAデカルボキシラーゼ阻害剤として有用なピペリジン化合物
ATE375810T1 (de) 2003-08-01 2007-11-15 Chugai Pharmaceutical Co Ltd Cyanoamid-verbindungen als nützliche malonyl-coa decarboxylase-hemmer
TWI374883B (en) * 2004-08-16 2012-10-21 Theravance Inc Crystalline form of a biphenyl compound
NZ566537A (en) 2005-09-30 2010-10-29 Pulmagen Therapeutics Asthma L Quinolines and their therapeutic use
GB0519969D0 (en) * 2005-09-30 2005-11-09 Argenta Discovery Ltd Quinoline compounds
PL2139881T3 (pl) * 2007-04-04 2012-04-30 Pulmagen Therapeutics Asthma Ltd Chinoliny i ich zastosowanie terapeutyczne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IE903911A1 (en) * 1989-11-20 1991-05-22 Ici Plc Diazine derivatives
US5049565A (en) * 1990-12-07 1991-09-17 Merck & Co., Inc. Microbial transformation process for preparing anti-hypertensive products
GB9102727D0 (en) * 1991-02-08 1991-03-27 Ici Plc Pharmaceutical agent
US5157040A (en) * 1991-04-05 1992-10-20 Merck & Co., Inc. Substituted quinolines as angiotensin ii antagonists

Also Published As

Publication number Publication date
CN1075720A (zh) 1993-09-01
EP0556060A1 (en) 1993-08-18
PL172241B1 (pl) 1997-08-29
CA2089185A1 (en) 1993-08-15
NO930520D0 (no) 1993-02-12
AU656454B2 (en) 1995-02-02
HUT69694A (en) 1995-09-28
ZA93531B (en) 1993-08-26
AU3299193A (en) 1993-08-19
NZ245757A (en) 1995-09-26
IL104623A0 (en) 1993-06-10
CN1044243C (zh) 1999-07-21
RU2122540C1 (ru) 1998-11-27
FI930621A7 (fi) 1993-08-15
JPH05286939A (ja) 1993-11-02
NO930520L (no) 1993-08-16
FI930621A0 (fi) 1993-02-12
KR930017891A (ko) 1993-09-20
HU9300386D0 (en) 1993-04-28
HU217627B (hu) 2000-03-28
PL297713A1 (en) 1993-08-23
IL104623A (en) 1996-12-05
MX9300742A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
TW297025B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN109678796B (zh) Pd-1/pd-l1小分子抑制剂及其制备方法和用途
CA2862289C (en) Modulators of methyl modifying enzymes, compositions and uses thereof
JP7097358B2 (ja) アルファvインテグリン阻害剤としての3-置換プロピオン酸
JP2654537B2 (ja) ベンゾヘテロ環化合物
JP6786527B2 (ja) Nrf2レギュレーター
FI100241B (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(alkok sipyrimidinyyli)-piperatsiinien valmistamiseksi
KR100224135B1 (ko) 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
IE903286A1 (en) 3-(1-substituted-4-piperazinyl)-1h-indazoles, a process for¹their preparation and their use as medicaments
CN107873031A (zh) 作为tnf活性调节剂的苯并噁嗪酮衍生物及其类似物
WO2018183712A1 (en) Pyrrolo[1,2-b]pyridazine compounds and compositions useful for treating disorders related to kit and pdgfr
CA3229566A1 (en) Sos1 inhibitor and use thereof
EP3704112B1 (en) Alkene spirocyclic compounds as farnesoid x receptor modulators
PT751944E (pt) Tiazolidinas e oxazolidinas substituidas por um anel piridina e sua utilizacao como agentes hipoglicemicos
EP3704106A1 (en) Alkene compounds as farnesoid x receptor modulators
CN116600808A (zh) 一类作为kras突变体g12c抑制剂的四氢萘啶类衍生物、其制备方法及其应用
CN114096545A (zh) 新杂环化合物
TW211568B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR20190094187A (ko) 축합 고리기 아자시클로부틸 트리아졸 유도체, 이의 제조 방법 및 의약에서의 이의 용도
KR100201515B1 (ko) 1-(치환된 피리디닐아미노)-1에이치-인돌-5-일 치환된 카바메이트, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN113149996B (zh) 一种作为cdk9抑制剂的多环酰胺类衍生物、其制备方法及用途
CN114072398A (zh) 抑制tdg活性的化合物
WO2004089939A1 (en) Condensed furan derivatives as adenosine antagonists
EP0216323A2 (en) Quinolonecarboxylic acid derivatives and their preparation
JPS63264461A (ja) ベンゾヘテロ環化合物